APO Research

APO RESEARCH · REPORT

Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Selected research

Industry Growth & Trends

Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032

Market perspective

The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) include Whistler, The Lab, Select Oil, Pharmahemp, NuLeaf Naturals, Medical Marijuana, Kazmira, K.I.N.D. Concentrates and HempLife Today, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Company

Whistler

The Lab

Select Oil

Pharmahemp

NuLeaf Naturals

Medical Marijuana

Kazmira

K.I.N.D. Concentrates

HempLife Today

Green Road

Freedom Leaf

Folium Biosciences

ENDOCA

Emblem Cannabis Oils

CW Hemp/CW Botanicals

CBD American Shaman

Canopy Growth Corporation

Cannavest

Aphria

Absolute Terps

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tetrahydrocannabinol (THC) Table 2. Major Company of Cannabidiol (CBD) Table 3. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type (2021-2026) Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2026) & (US$/Ton) Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type (2027-2032) Table 13. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2027-2032) & (US$/Ton) Table 14. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 15. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 17. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 21. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (US$ Million) Table 24. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends Table 25. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers Table 26. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges Table 27. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints Table 28. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Company (2021-2026) Table 30. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Company (2021-2026) & (Tons) Table 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Company (2021-2026) Table 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Major Company Production Sites and Headquarters Table 35. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company, Product Type & Application Table 36. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (Tons) Table 41. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Region (2021-2026) Table 44. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032) & (Tons) Table 46. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Region (2027-2032) Table 49. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 52. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application (2021-2026) Table 55. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2026) & (US$/Ton) Table 56. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 57. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application (2027-2032) Table 60. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2027-2032) & (US$/Ton) Table 61. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 62. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 64. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 68. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (US$ Million) Table 71. Whistler Company Information Table 72. Whistler Business Overview Table 73. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 75. Whistler Recent Development Table 76. The Lab Company Information Table 77. The Lab Business Overview Table 78. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 80. The Lab Recent Development Table 81. Select Oil Company Information Table 82. Select Oil Business Overview Table 83. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 85. Select Oil Recent Development Table 86. Pharmahemp Company Information Table 87. Pharmahemp Business Overview Table 88. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 90. Pharmahemp Recent Development Table 91. NuLeaf Naturals Company Information Table 92. NuLeaf Naturals Business Overview Table 93. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 95. NuLeaf Naturals Recent Development Table 96. Medical Marijuana Company Information Table 97. Medical Marijuana Business Overview Table 98. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 100. Medical Marijuana Recent Development Table 101. Kazmira Company Information Table 102. Kazmira Business Overview Table 103. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 105. Kazmira Recent Development Table 106. K.I.N.D. Concentrates Company Information Table 107. K.I.N.D. Concentrates Business Overview Table 108. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 110. K.I.N.D. Concentrates Recent Development Table 111. HempLife Today Company Information Table 112. HempLife Today Business Overview Table 113. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 115. HempLife Today Recent Development Table 116. Green Road Company Information Table 117. Green Road Business Overview Table 118. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 120. Green Road Recent Development Table 121. Freedom Leaf Company Information Table 122. Freedom Leaf Business Overview Table 123. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 125. Freedom Leaf Recent Development Table 126. Folium Biosciences Company Information Table 127. Folium Biosciences Business Overview Table 128. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 130. Folium Biosciences Recent Development Table 131. ENDOCA Company Information Table 132. ENDOCA Business Overview Table 133. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 135. ENDOCA Recent Development Table 136. Emblem Cannabis Oils Company Information Table 137. Emblem Cannabis Oils Business Overview Table 138. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 139. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 140. Emblem Cannabis Oils Recent Development Table 141. CW Hemp/CW Botanicals Company Information Table 142. CW Hemp/CW Botanicals Business Overview Table 143. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 144. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 145. CW Hemp/CW Botanicals Recent Development Table 146. CBD American Shaman Company Information Table 147. CBD American Shaman Business Overview Table 148. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 149. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 150. CBD American Shaman Recent Development Table 151. Canopy Growth Corporation Company Information Table 152. Canopy Growth Corporation Business Overview Table 153. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 154. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 155. Canopy Growth Corporation Recent Development Table 156. Cannavest Company Information Table 157. Cannavest Business Overview Table 158. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 159. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 160. Cannavest Recent Development Table 161. Aphria Company Information Table 162. Aphria Business Overview Table 163. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 164. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 165. Aphria Recent Development Table 166. Absolute Terps Company Information Table 167. Absolute Terps Business Overview Table 168. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 169. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 170. Absolute Terps Recent Development Table 171. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 172. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 173. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 174. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032) & (Tons) Table 175. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Country (2027-2032) Table 176. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026) & (US$ Million) Table 178. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country (2021-2026) Table 179. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share Forecast by Country (2027-2032) Table 181. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 182. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 183. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 184. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032) & (Tons) Table 185. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Country (2027-2032) Table 186. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026) & (US$ Million) Table 188. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country (2021-2026) Table 189. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 193. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 194. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032) & (Tons) Table 195. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026) & (US$ Million) Table 198. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country (2021-2026) Table 199. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share Forecast by Country (2027-2032) Table 201. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 202. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 203. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 204. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032) & (Tons) Table 205. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Country (2027-2032) Table 206. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026) & (US$ Million) Table 208. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country (2021-2026) Table 209. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 213. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2026) Table 214. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032) & (Tons) Table 215. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026) & (US$ Million) Table 218. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country (2021-2026) Table 219. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share Forecast by Country (2027-2032) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List Table 224. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Image Figure 2. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (2021-2032) & (US$ Million) Figure 4. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032) & (Tons) Figure 5. Tetrahydrocannabinol (THC) Image Figure 6. Global Tetrahydrocannabinol (THC) Sales YoY Growth (2021-2032) & (Tons) Figure 7. Cannabidiol (CBD) Image Figure 8. Global Cannabidiol (CBD) Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Type 2025 VS 2032 Figure 11. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type in 2025 Figure 12. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type in 2025 Figure 13. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceuticals Industry Image Figure 24. Global Pharmaceuticals Industry Sales YoY Growth (2021-2032) & (Tons) Figure 25. Food Industry Image Figure 26. Global Food Industry Sales YoY Growth (2021-2032) & (Tons) Figure 27. Cosmetics Industry Image Figure 28. Global Cosmetics Industry Sales YoY Growth (2021-2032) & (Tons) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Application 2025 VS 2032 Figure 33. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application in 2025 Figure 34. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application in 2025 Figure 35. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share in Value by Application in 2025 Figure 43. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Whistler
  • The Lab
  • Select Oil
  • Pharmahemp
  • NuLeaf Naturals
  • Medical Marijuana
  • Kazmira
  • K.I.N.D. Concentrates
  • HempLife Today
  • Green Road
  • Freedom Leaf
  • Folium Biosciences
  • ENDOCA
  • Emblem Cannabis Oils
  • CW Hemp/CW Botanicals
  • CBD American Shaman
  • Canopy Growth Corporation
  • Cannavest
  • Aphria
  • Absolute Terps

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Type
  6. 1.3.1 Tetrahydrocannabinol (THC)
  7. 1.3.2 Cannabidiol (CBD)
  8. 1.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Type
  9. 1.4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  2. 2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers
  3. 2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (2021-2026)
  2. 3.2 Global Top Players by Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2026)
  3. 3.3 Global Top Players by Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price (2021-2026)
  4. 3.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Major Company Production Sites & Headquarters
  6. 3.6 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company, Product Type & Application
  7. 3.7 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Tier 1, Tier 2, and Tier 3
4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Regional Status and Outlook
  1. 4.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Historic Market Size by Region
  3. 4.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecasted Market Size by Region
  7. 4.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Application
  1. 5.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Application
  2. 5.1.1 Pharmaceuticals Industry
  3. 5.1.2 Food Industry
  4. 5.1.3 Cosmetics Industry
  5. 5.1.4 Other
  6. 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Application
  7. 5.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Whistler
  2. 6.1.1 Whistler Company Information
  3. 6.1.2 Whistler Business Overview
  4. 6.1.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  6. 6.1.5 Whistler Recent Developments
  7. 6.2 The Lab
  8. 6.2.1 The Lab Company Information
  9. 6.2.2 The Lab Business Overview
  10. 6.2.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  12. 6.2.5 The Lab Recent Developments
  13. 6.3 Select Oil
  14. 6.3.1 Select Oil Company Information
  15. 6.3.2 Select Oil Business Overview
  16. 6.3.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  18. 6.3.5 Select Oil Recent Developments
  19. 6.4 Pharmahemp
  20. 6.4.1 Pharmahemp Company Information
  21. 6.4.2 Pharmahemp Business Overview
  22. 6.4.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  24. 6.4.5 Pharmahemp Recent Developments
  25. 6.5 NuLeaf Naturals
  26. 6.5.1 NuLeaf Naturals Company Information
  27. 6.5.2 NuLeaf Naturals Business Overview
  28. 6.5.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  30. 6.5.5 NuLeaf Naturals Recent Developments
  31. 6.6 Medical Marijuana
  32. 6.6.1 Medical Marijuana Company Information
  33. 6.6.2 Medical Marijuana Business Overview
  34. 6.6.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  36. 6.6.5 Medical Marijuana Recent Developments
  37. 6.7 Kazmira
  38. 6.7.1 Kazmira Company Information
  39. 6.7.2 Kazmira Business Overview
  40. 6.7.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  42. 6.7.5 Kazmira Recent Developments
  43. 6.8 K.I.N.D. Concentrates
  44. 6.8.1 K.I.N.D. Concentrates Company Information
  45. 6.8.2 K.I.N.D. Concentrates Business Overview
  46. 6.8.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  48. 6.8.5 K.I.N.D. Concentrates Recent Developments
  49. 6.9 HempLife Today
  50. 6.9.1 HempLife Today Company Information
  51. 6.9.2 HempLife Today Business Overview
  52. 6.9.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  54. 6.9.5 HempLife Today Recent Developments
  55. 6.10 Green Road
  56. 6.10.1 Green Road Company Information
  57. 6.10.2 Green Road Business Overview
  58. 6.10.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  60. 6.10.5 Green Road Recent Developments
  61. 6.11 Freedom Leaf
  62. 6.11.1 Freedom Leaf Company Information
  63. 6.11.2 Freedom Leaf Business Overview
  64. 6.11.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  66. 6.11.5 Freedom Leaf Recent Developments
  67. 6.12 Folium Biosciences
  68. 6.12.1 Folium Biosciences Company Information
  69. 6.12.2 Folium Biosciences Business Overview
  70. 6.12.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  72. 6.12.5 Folium Biosciences Recent Developments
  73. 6.13 ENDOCA
  74. 6.13.1 ENDOCA Company Information
  75. 6.13.2 ENDOCA Business Overview
  76. 6.13.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  78. 6.13.5 ENDOCA Recent Developments
  79. 6.14 Emblem Cannabis Oils
  80. 6.14.1 Emblem Cannabis Oils Company Information
  81. 6.14.2 Emblem Cannabis Oils Business Overview
  82. 6.14.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  84. 6.14.5 Emblem Cannabis Oils Recent Developments
  85. 6.15 CW Hemp/CW Botanicals
  86. 6.15.1 CW Hemp/CW Botanicals Company Information
  87. 6.15.2 CW Hemp/CW Botanicals Business Overview
  88. 6.15.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  90. 6.15.5 CW Hemp/CW Botanicals Recent Developments
  91. 6.16 CBD American Shaman
  92. 6.16.1 CBD American Shaman Company Information
  93. 6.16.2 CBD American Shaman Business Overview
  94. 6.16.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  96. 6.16.5 CBD American Shaman Recent Developments
  97. 6.17 Canopy Growth Corporation
  98. 6.17.1 Canopy Growth Corporation Company Information
  99. 6.17.2 Canopy Growth Corporation Business Overview
  100. 6.17.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  102. 6.17.5 Canopy Growth Corporation Recent Developments
  103. 6.18 Cannavest
  104. 6.18.1 Cannavest Company Information
  105. 6.18.2 Cannavest Business Overview
  106. 6.18.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  108. 6.18.5 Cannavest Recent Developments
  109. 6.19 Aphria
  110. 6.19.1 Aphria Company Information
  111. 6.19.2 Aphria Business Overview
  112. 6.19.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  114. 6.19.5 Aphria Recent Developments
  115. 6.20 Absolute Terps
  116. 6.20.1 Absolute Terps Company Information
  117. 6.20.2 Absolute Terps Business Overview
  118. 6.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  120. 6.20.5 Absolute Terps Recent Developments
7 North America by Country
  1. 7.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
  2. 7.1.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  4. 7.1.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  6. 7.2.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026)
  8. 7.2.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
  2. 8.1.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  4. 8.1.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  6. 8.2.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
  2. 9.1.1 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  6. 9.2.1 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
  2. 10.1.1 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  4. 10.1.3 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  6. 10.2.1 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026)
  8. 10.2.3 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country
  2. 11.1.1 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country
  6. 11.2.1 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Analysis
  2. 12.1.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process
  7. 12.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
  10. 12.2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research